IncFact
Company Profile: Revenue, Growth, Competition

NEUROPACE - Revenue, Growth & Competitor Profile

455 N. Bernardo Avenue
Mountain View, CA 94043

www.neuropace.com
Last updated:

Company Awards

Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 
VC / Private Equity
Venture Capital / Private Equity

Company Profile & Financial Information for Neuropace

Access the complete profile.


Fast Facts

Revenue$10 - $50 million    Exact Revenue in Premium Report
Employees100 - 500Exact Employee Count Available in Premium Report
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes33451
33911
Note: Revenues for privately held companies are statistical evaluations.


Neuropace's Business Operations Profile shows critical firmographic facts:
  • What is the company's size? (Revenue and employees)
  • What industry is the company in?

Neuropace Revenue and Growth Rate

Neuropace Revenue Est.
($ Million)
Growth Rate (%)# Employees
2016 Details in Premium Report
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Neuropace's revenues are gauged from an analysis of company filings.



Investor Activity

Neuropace has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
August 8, 2017 26 90%$80 MM
Complete list of funding rounds and total amounts in the Company Report




Neuropace's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Neuropace Revenue (Sales) Neuropace Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Neuropace is developing and marketing. Neuropace's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
SIMPLESTART
Operating software to be embedded in medical apparatus for treating neurological disorders
YOUR WINDOW TO THE BRAIN
Medical devices, namely, apparatus for treatment of neurological disorders
TARGETED TREATMENT WHEN IT'S NEEDED
medical devices, namely, apparatus for treatment of neurological disorders

See all trademarks and details in the Full Report.


Patent Applications

Patent applications show Neuropace's intellectual property, its current capabilities and future direction. Neuropace has applied for 98 patents since 2009. Neuropace's most recent patent was filed in August 2017 for Integrated Backup Band For Use In Forming An Enclosure For A Medical Device. An implantable medical device includes an enclosure having a sidewall and a welded seam in the sidewall, the seam extends along a perimeter of the enclosure. A thermoform is located adjacent a surface of the enclosure and is secured in place within the enclosure. A metalized surface is located adjacent an interior surface of the enclosure sidewall and is secured in place by the thermoform. The metalized surface extends along a perimeter of the enclosure and is configured to obstruct laser energy during a weld seam process. The metalized surface may be provided as a separate backup band component or may be integrated in a perimeter sidewall of the thermoform.


Patent Application Date
Complete list of patent applications




Recession Risk

Determine whether Neuropace grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Neuropace is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Neuropace vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Neuropace, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
ALEXION PHARMACEUTICALSNew Haven, CT100 
CEPHALONFrazer, PA86 
VERTEX PHARMACEUTICALSBoston, MA82 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM72 
ILLUMINASan Diego, CA67 
QUINTILESDurham, NC55 




Nearby Competitors

These companies are similar in business line and location to Neuropace. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
SRI INTERNATIONALMenlo Park, CA100 
GENOMIC HEALTHRedwood City, CA66 
EXPONENTMenlo Park, CA66 
EXELIXISSouth San Francisco, CA64 
PHASE FORWARDRedwood Shores, CA45 
SOLAZYMESouth San Francisco, CA38 




Similar Sized Companies near Mountain View

These are similar in size and location to Neuropace.

Company HeadquartersRevenue ($ MM)
MINERVA SURGICALRedwood City, CA99 
CBR SYSTEMSSan Bruno, CA99 
OPENGOVRedwood City, CA100 
COIT SERVICESBurlingame, CA100 
NGM BIOPHARMACEUTICALSSouth San Francisco, CA100 
CARLSEN MOTOR CARSRedwood City, CA100 
GRID DYNAMICS INTERNATIONALMenlo Park, CA99 
HOLT TOOL & MACHINERedwood City, CA99 
ARTICHOKE ENTERPRISESSan Bruno, CA99 
SERRAMONTE FORDColma, CA99 
TINY PRINTSSunnyvale, CA99 
KNOWLEDGE NETWORKSMenlo Park, CA98 




Fastest Growing Competitors

These companies are in the same general field as Neuropace and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Neuropace Competitors